WIB22: Suma Kr­ish­nan co-found­ed a com­pa­ny to de­vel­op a treat­ment for ‘the worst dis­ease you’ve nev­er heard of’

This pro­file is part of End­points News’ 2022 spe­cial re­port about Women in Bio­phar­ma R&D. You can read the full re­port here.

Af­ter spend­ing time with pa­tients who were di­ag­nosed with what some call “the worst dis­ease you’ve nev­er heard of,” Suma Kr­ish­nan ded­i­cat­ed her­self to find­ing a treat­ment.

Kr­ish­nan, who is the co-founder and chief op­er­at­ing of­fi­cer of Krys­tal Biotech, spear­head­ed a gene ther­a­py gel that showed promise in a late-stage clin­i­cal tri­al for dy­s­troph­ic epi­der­mol­y­sis bul­losa. The FDA is re­view­ing whether to ap­prove the ther­a­py and will de­cide by Feb­ru­ary.

To read Endpoints News become a free subscriber

Unlock this article instantly, along with access to limited free monthly articles and our suite of newsletters

SIGN UP LOG IN